Pages that link to "Q61766631"
Jump to navigation
Jump to search
The following pages link to Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis (Q61766631):
Displaying 25 items.
- Future Vaccination Strategies against Tuberculosis: Thinking outside the Box (Q22252427) (← links)
- Vaccines against tuberculosis: where are we and where do we need to go? (Q26992233) (← links)
- Prime-boost approaches to tuberculosis vaccine development (Q27024526) (← links)
- Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis (Q27315911) (← links)
- Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model (Q27332450) (← links)
- Host cell-induced components of the sulfate assimilation pathway are major protective antigens of Mycobacterium tuberculosis (Q30580895) (← links)
- Differential contribution of the repeats to heparin binding of HBHA, a major adhesin of Mycobacterium tuberculosis (Q34189467) (← links)
- Comparison of BCG prime-DNA booster and rBCG regimens for protection against tuberculosis (Q34290885) (← links)
- Risk stratification of latent tuberculosis defined by combined interferon gamma release assays (Q34389498) (← links)
- A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis (Q35033838) (← links)
- IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization (Q36947326) (← links)
- Pyoderma gangrenosum-like skin changes after subcutaneous administration of low molecular weight heparin. (Q36977817) (← links)
- Mucosal vaccination against tuberculosis using inert bioparticles (Q37264883) (← links)
- New vaccines for tuberculosis (Q37757648) (← links)
- HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis (Q38303966) (← links)
- Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination (Q39473407) (← links)
- Construction of a DNA Vaccine Encoding Mtb32C and HBHA Genes of Mycobacterium tuberculosis (Q41224466) (← links)
- Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis (Q41547703) (← links)
- A study on the immune response induced by a DNA vaccine encoding Mtb32C-HBHA antigen of Mycobacterium tuberculosis (Q47131991) (← links)
- Immunogenicity of heparin-binding hemagglutinin expressed by Pichia pastoris GS115 strain (Q49874170) (← links)
- Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis (Q51054761) (← links)
- Report of the 2nd “French Clinical Vaccinology Meeting Jean-Gerard Guillet”: Immunization and respiratory diseases (Q56833872) (← links)
- Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria (Q58552059) (← links)
- Prolonged intervals during Mycobacterium tuberculosis subunit vaccine boosting contributes to eliciting immunity mediated by central memory-like T cells (Q88740853) (← links)
- Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model (Q90999771) (← links)